Oral ST1481 in Adults With Malignant Glioma: a Phase I-II Clinical Trial.

Trial Profile

Oral ST1481 in Adults With Malignant Glioma: a Phase I-II Clinical Trial.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 15 Jul 2013

At a glance

  • Drugs Gimatecan (Primary)
  • Indications Anaplastic astrocytoma; Glioblastoma; Glioma; Oligodendroglioma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 15 Jul 2013 Planned number of patients changed from 59 to 83 as reported by ClinicalTrials.gov (NCT00087061).
    • 15 Jul 2013 Planned number of patients changed from 59 to 83 as reported by ClinicalTrials.gov (NCT00087061).
    • 15 Jul 2013 Additional trial identifier (NCT00087061) identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top